The manuscript describes deliberations and decisions amved at by a panel of experienced toxicologic pathologists, attempting to deal with a continuing problem in the safety (or risk) evaluation of drugs and chemicals using one strain ofrat. The major and significant suggested change is to replace the term neoplastic nodule with hepatocelliilar hyperplasia and hepatocellirlar adenonla, and then to re-evaluate the results and implications of shifting back to more conventional diagnostic terms. This is a rational and commendable move on the part of the NTP and reflects a reality of group efforts to exercise common sense, act responsibly, and provide leadership in critical issues.
INTRODUCTION
and diagnosis of hepatoproliferative lesions should be prefaced by an explanation of the diagnostic process. Diagnostic histopathology is a process ofpredicting the biologic nature of a lesion from its morphologic appearance. This process must be performed with due consideration of published literature relating to experimental findings and will be influenced by the pathologist's Own previous experience and his experience with each particular study. Thus, the no-TOXICOLOGIC PATHOLOGY menclature and diagnosis chosen for each observed lesion reflects the pathologist's perception of the nature of the lesion. BACKGROUND Conformity and uniformity of pathologic diagnostic terminology are important to the National Toxicology Program (NTP) Testing Program. With over 65 consulting pathologists evaluating histopathologic material from numerous NTP toxicity and carcinogenicity studies, uniform diagnostic terminology is necessary to insure a useful historic data base and to permit comparison of results among studies. Recommended diagnostic terminology for specific lesions is established by NTP pathologists based on experience, scientific literature, and opinions solicited from practicing toxicologic pathologists familiar with strains and stocks of rodents used by the NTP. Diagnostic criteria and recommended terminology are communicated to pathologists participating in NTP studies by letter and at annual workshops. The NTP further insures consistent and accurate diagnoses by means of a thorough pathology peer review process (4, 14, 15).
In the process of conducting in-depth review of lesions from numerous toxicity and carcinogenicity studies in rodents, NTP pathologists have a unique opportunity to examine a wider spectrum of rare as well as common lesions than are generally observed by pathologists in individual toxicology laboratories. Consequently, the NTP is in a favorable position to establish diagnostic criteria and nomenclature for such lesions. We have recently reviewed existing classification schemes of proliferative hepatocellular lesions in the Fischer 344 rat and, in light of our collective experience during the review of over 100 two-year studies during the past four years, we feel that some changes in diagnostic terminology are appropriate.
Prior to 1975, there was no standardized nomenclature for hepatoproliferative lesions in the rat. One pathologist's nodirlar hyperplasia was another pathologist's hepatoriia and still another's carcinoiiia. Consequently, evaluation of the carcinogenic potential of a chemical was sometimes more dependent on an individual pathologist's terminology than on the histologic nature of the actual lesions. Recommendation of the term neoplastic nodrile in 1975 by a group of pathologists experienced in evaluating rodent hepatoproliferative lesions (26) , its endorsement by a second group of pathologists in 1980 (1 1)' and its use in the NCVNTP Carcinogenicity Testing Program for the past 9 years have had a beneficial and positive impact in bringing about consistency in diagnostic terminology for a spectrum of nonmalignant hepatoproliferative lesions commonly encountered in the rat. However, there has never been unanimous endorsement of the term neoplastic nodtile, and its biologic potential has been debated for years. In fact, in both publications recommending the term neoplastic nodiile, it was implied (26) or stated (1 1) that a minority of the participating pathologists felt that there was a nonneoplastic, nodular, hyperplastic lesion ofthe rat h e r which should not be included under the term neoplastic nodiile.
As originally defined, neoplastic nodiile was generally a spherical lesion several liver lobules in dimension and was characterized by loss or distortion of normal liver architecture. The hepatocytes comprising this lesion could exhibit varying degrees of cytoplasmic and nuclear alteration. An important feature of the rteoplastic nodtile was ". . . the architectural distortion and sharp demarcation of the nodule from surrounding liver around at least a portion of its periphery . . ." (26) . (25) . However, because of the rigid classification scheme being followed, such hyperplastic lesions were diagnosed as neoplastic nodules. In 1983, we undertook the task of reexamining the classification of hepatoproliferative lesions in the rat in light of the types of lesions being seen in the NTP carcinogenicity testing effort. The purpose of this communication is to define the criteria for NTP's recommended nomenclature for rat hepatoproliferative lesions and to document the steps leading to adoption of the new nomenclature. It is important to remember that the practicing toxicologic pathologist invariably makes a diagnosis based on the morphologic features of a lesion without definitive knowledge of the biologic behavior of that lesion. Judgments regarding the 'presumed' behavior of a specific lesion are derived from examination of the effects of the specific treatment on the whole group of animals being evaluated and from having observed the consequences of morphologically similar lesions in other toxicity and carcinogenicity studies.
SOURCE OF MATERIALS
Most materials used for review originated from the NCI/NTP Carcinogenicity Testing Program and were obtained from the NTP Archives or from ongoing carcinogenicity studies not yet archived. In all cases, the liver lesions reviewed were from treated or control Fischer 344/N rats.
A representative set of 36 hematoxylin and eosinstained slides of proliferative liver lesions from rats was prepared and sent to nine consulting pathologistsand twoNTPpathologists. OnMarch 15, 1983 , these pathologists met at the National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, to discuss the selected lesions and to consider issues related to nomenclature. The The lesions reviewed ranged from foci of cellular alteration to hepatocellular caicinomas. The consensus was that there was a valid basis for revising the existing nomenclature and that the most expeditious means of so doing would be for the NTP to accept the responsibility for that task. Consequently, NTP pathologists drafted criteria for a modified lexicon relative to hepatoproliferative lesions of rats.
These draft criteria for a modified nomenclature of hepatoproliferative lesions were then applied to lesions diagnosed as rieoplasric riodtrles or hepatocellular carcinomas from fifteen recently completed two-year carcinogenicity studies in rats. Attention was placed primarily on potential neoplastic lesions. A subset of these lesions was then reviewed in a "blind" fashion by several NTP pathologists, using the draft criteria. The NTP pathologists who met in February 1984 to review selected lesions were G. A. Boorman, S. Eustis, L. Hall, R. R. Maronpot, C. A. Montgomery, H. Solleveld, and M. Wolfe. On the basis of this review, the draft criteriawere further refined and are herein described to define the recommended NTP nomenclature for hepatoproliferative lesions of the rdt.
RESULTS
The current NTP nomenclature for rat hepatoproliferative lesions includes: a) Foci of cellular alteration (clear cell foci, eosinophilic or "ground glass" foci, basophilic foci, and mixed foci), b) Hepatocellular adenoma, c) Hepatocellular carcinoma, and d) Hyperplasia (either focal or multifocal).
Foci of Cellirlar Alreralion. These previously described ( I 1, 19, 26, 28) localized lesions are recognized by virtue of tinctorial variation from surrounding hepatic parenchyma. Foci vary in size from less than a hepatic lobule up to several lobules ("areas of cellular alteration"). Foci usually merge imperceptibly with surrounding parenchyma (Fig. 1 ) and may cause slight compression.
Further classification of foci of cellular alteration is encouraged by the NTP. The NTP currently identifies four types of cellular alteration, viz., clear cell, eosinophilic, basophilic, and mixed, using previously published classification criteria (1 1,26). Based upon NTP sponsored studies using the neonatal rat liver tumor initiatiodpromotion model described by Peraino (1 8, 2 l), clcar cell foci identified in hematoxylin and eosin-stained sections frequently correspond to gamma glutamyl transpeptidase (GGT) positive foci in appropriately stained serial sections. However, it should be noted that not all GGT-positive foci are composed of cells with clear cytoplasm. Some GGT-positive foci have no detectable hematoxylin and eosin counterpart in serial sections. Clear cell foci are generally periodic acid Schiff positive suggesting that clear areas in the cytoplasm represent glycogen depositions dissolved out in aqueous fixatives. Based upon empirical observations at NTP and other information (1, 28), basophilic foci are observed in increasing incidence as a function of age in Fischer 344 rats and may reach 100% incidence in two-year old females. Basophilic foci have been regarded as more indicative of increased risk for neoplasia than other types of foci (10, 19, 20, 26) , but the NTP experience does not support this opinion (1 5).
A subcapsular focus comprised of vacuolated hepatocytes may occasionally be observed in a fortuitous section at the attachment site ofthe falciform ligament to the liver (Fig. 2) . This change, which can often be observed grossly, is believed to be related to mechanical stress. Consequently, its significance is probably different from that of foci of cellular alteration found elsewhere in the liver.
Heparocellirlar Aderiorm These discrete proliferations are sharply demarcated from surrounding liver by compression and tinctorial staining differ- at SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from ences (Figs. 3,4) . The hepatic plates of the adenoma are usually not continuous with the surrounding liver plates but impinge on them at an angle. There is loss of the normal lobular architecture. Adenomas are often characterized by an increased mitotic index, may contain small areas of cellular atypia (e.g., pleomorphic nuclei, coarsely clumped chromatin, large nucleoli, increased nucleus to cytoplasm ratio, cytoplasmic basophilia, cytoplasmic pleomorphism, altered cell to cell relationship), and usually have an irregular growth pattern (Figs. 5 , 6 ). Cells within an adenoma may be degenerated, hypertrophic, and/or contain intracytoplasmic vacuoles. Important diagnostic features distinguishing hepatocellular adenomas from hepatocellular hyperplasias are (1) more prominent compression of surrounding hepatic parenchyma, (2) loss of normal lobular architecture, (3) larger size, and (4) cytologic atypia.
As observed in two-year carcinogenicity studies, hepatocellular adenomas in rats usually occur as single nodular lesions but occasionally multiple adenomas are present in a single liver. While there is generally loss of normal lobular architecture in an adenom'a, the occurrence of portal triads within adenomas has occasionally been seen. Hepatocellular adenomas do not usually contain large areas of necrosis although torsion and subsequent infarction of peripherally located adenomas have been observed. Hepatocelliilar Carcitioma. The diagnostic criteria for hepatocellular carcinoma in the rat are well documented in the literature (1 1, 26, 28) , and it is seldom a problem to obtain agreement on diagnosis of these neoplasms. Diagnostic criteria of importance include cellular atypia, irregular shape, local invasiveness, haphazardly arranged cells (Fig. 7) , broad sheets of cells, trabecular patterns (Fig. S) , and gland-like formations (Figs. 9, 10) . Occasionally, adenomas contain focal areas of marked cellular atypia sufficient to warrant a diagnosis of carcinoma. Vascular invasion or metastases arc not essential for making the diagnosis of carcinoma but can be observed on occasion. As is the situation for adenomas, hepatocellular carcinomas are not usually multiple in standard two-year carcinogenicity studies in rats. Hemorrhage and necrosis may be present in hepatocellular carcinomas.
Hepatocelliilar Hyperplasia. Hepatocellular hyperplasia is infrequently observed in conventional two-year carcinogenicity studies but when present is usually a multifocal change (Figs. 11-16 ). It is seen in livers damaged by hepatotoxic chemicals and in this context may be considered a regenerative hyperplasia. When accompanied by periportal fibrosis, oval cell proliferation, bile duct proliferation, and/or hepatocellular degeneration, the condition may resemble cirrhosis as described in human pathology texts (5, 24, 25) . However, in rats there is generally less fibrosis than is typical of cirrhosis in humans. The lesion is seen with repeated toxic injury to the liver and represents the combined reaction to injury and attempted regeneration of hepatic parenchyma. When the constellation of degenerative, chronic inflammatory, and regenerative changes is present, the diagnosis of multifocal hyperplasia should be supplemented with additional diagnoses, e.g., oval cell proliferation, fibrosis, degeneration, to permit more complete characterization of the lesions present. Hyperplasia is reserved for those proliferative lesions that are believed to occur secondary to a primary degenerative process in the liver.
Focal hyperplasia consists of a spherical proliferation of hepatocytes without cytologic atypia. The hepatic lobular architecture is present, albeit distorted, portal triads can often be found within the focal hyperplasia, and there is compression of adjacent normal parenchyma. Cells within a focus of hyperplasia are usually uniform and have a homogeneous growth pattern but features such as hypertrophy, cytoplastic vacuolation, and an increased number of mitoses may be present.
Often the distinction between focal hyperplasia and a focus of cytologic alteration rests solely on the degree of cytologic alteration and compression of surrounding hepatic parenchyma. Hyperplastic le: sions may reach several millimeters in diameter and are frequently seen as relatively distinct lesions in histologic sections. Based upon review of over 100 two-year carcinogenesis studies at NTP, hepatocellular hyperplasia is a frequent finding in livers of Fischer 344 rats with mononuclear cell leukemia. Whether. the hepatocellular hyperplasia is focal or multifocal is presumably dependent upon the degree of liver degeneration secondary to the anemia and resultant anoxia characteristic of mononuclear cell leukemia.
Other Selected Hepatic Lesions. Localized vascular ectasia, bile duct ectasia, and cystic degeneration (compatible with spongiosis hepatis as described by Bannasch et al (2)) are occasionally observed within hepatoproliferative lesions as well as in othenvise normal hepatic parenchyma. The significance of these changes with respect to hepatic neoplasia is not known. When localized within normal hepatic parenchyma, these changes can produce slight evidence of compression of adjacent hepatic parenchyma. Such lesions should not be diagnosed as foci of alteration, focal hyperplasia, or hcpatocellular adenoma if the only change evident is ectasia or cystic degeneration. Fig. 15 showing a homogeneous population of hepatocytes in a hyperplastic focus. H&E. x80.
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brosis) has been observed in livers of Fischer 344 and other rats, usually in association with the administration of hepatotoxic chemicals (3, 6, 8, 9, 12, 13, 17, 22, 23) . This change is often manifested as interconnecting regions of proliferating connective tissue and bile ducts replacing hepatic parenchyma. Proliferating glandular epithelium is more prominent at the periphery of these lesions with central portions consisting of more avascular connective tissue. When viewed under low power magnification, cholangiofibrosis appears to resemble contracted areas of scar tissue within viable hepatic parenchyma. However, in some specific instances (e.g., administration of butter yellow, congeners of butter yellow, polychlorinated biphenyls, thioacetamide, coumarin, N-N-nitrosomorpholine) the proliferating glands and the associated desmoplasia may produce cholangiocarcinomas up to several millimeters in diameter (7, 9, 17, 22, 23) . Similar lesions produced by administration offuran have been found to grow rapidly upon subcutaneous transplantation and are locally invasive in the recipient; metastases of the original tumors have been observed rarely (1 6) . Morphologic distinctions between cholangiofibrosis and cholangiocarcinoma are difficult to make. In a given study, examination of the spectrum of lesions present, their natural history, and their reversibility should be considered in judgments regarding final diagnosis.
A specific protruding nodular lesion, hepatodiaphragmatic nodule, that is believed to represent a developmental malformation has been described as occurring in male and female Fischer 344 rats (28) . These grossly visible nodules are usually single and are typically located on the parietal surface of the liver near the hilus ofthe median lobes in immediate contact with the diaphragm near the diaphragmatic hiatus. The overlying diaphragm is usually attenuated and in some instances the hepatic nodule is herniated through the diaphragm. These nodules grossly resemble the adjacent normal hepatic parenchyma and histologically are comprised of hepatocytes arranged in normal lobules. The hepatocytes may appear completely normal or may contain unusually large or rod-shaped nucleoli giving them a distinctive appearance. Hepatodiaphragmatic nodules have been observed to contain a spectrum of changes such as bile duct hyperplasia, foci ofcellular alteration, hepatocellular degeneration, similar to those entities found elsewhere in the hepatic parenchyma. The incidence of this lesion has not been well documented but these nodules may be more common than reported (28) . Hepatodiaphragmatic nodules have been observed in young as well as aged Fischer 344 rats and grow proportional to normal liver growth.
DISCUSSION
Over the past nine years, there has been considerable vocal disapproval of the term iieoplastic nodule. The proceedings of the first annual meeting of the Society of Toxicologic Pathologists (27) reflect a typical debate on the appropriateness of the term neoplastic nodiile. The published proceedings represent an unaudited consensus of that Society that this term be censored from our diagnostic lexicon.
Objection to the term neoplastic nodrile generally focuses on three issues. The first relates to the connotation of neoplastic in the diagnosis. At issue here is the concept that an hepatic nodule, i.e., a focal proliferation of parenchymal cells, is not necessarily a neoplasm just because the accepted terminology contains the qualifier neoplastic. The second objection relates to the regulatory consequences of considering iieoplastic iiodiiles as true neoplasms. The third objection focuses on the obvious departure from conventional pathologic nomenclature. Use of the term neoplastic irodtile for rat hepatoproliferative lesions, then, suggests that there is some compelling reason for departing from conventional pathologic nomenclature. Such a reason is not now apparent.
There is a fourth less commonly invoked objection to the term neoplastic riodiile. This latter objection focuses on the nodiile portion of the term.
To some pathologists, nodule is appropriate for a grossly observed lesion but not for a microscopic lesion. The adjective iioditlar on the other hand, is a useful descriptive term equally applicable as a gross or microscopic qualifier. While the term nodtile or liver nodiile enjoys widespread use among researchers working with short-term in vivo liver tumor models and is useful in that context, to some pathologists it is not technically correct or accurate as a histologic diagnosis. Arguments that iiodiile is appropriate diagnostic terminology in view of our inability to definitively recognize a benign liver tumor (adenoma) beg the issue. One can never absolutely classify a tumor as benign in any epithelial tissue. We make our best considered judgment on a case by case basis. A strong argument for making no changes in the current classification of hepatoproliferative lesions of rats centers on our lack of understanding of the natural history or biologic behavior of these lesions within the context of conventional carcinogenicity studies and the realization that changing the name will not enhance our knowledge of the biologic behavior of the lesion. However, when one considers that we have more experimental experience with rodent liver tumors than with most other rodent tumors, the next logical questions are how much do we need to know, how long will it take t o gain that knowledge, and is it proper to make n o diagnostic modifications and take n o action until we know more? We currently formulate concIusions regarding carcinogenicity for virtually every organ in the body other than liver on the basis of far less information regarding biologic behavior than we currently have for liver. As pathologists, it is our charge to render diagnoses which are as definitive as possible, and which represent our best judgment and experience. To d o othenvise is a disservice.
The N T P recognizes four principal morphologic types of hepatocellular proliferative change. The term hyperplasia is reserved for proliferative lesions that are perceived t o be a secondary, nonneoplastic response to degenerative changes in the liver. I n contrast, the terms foci of cellirlar alteration, hepatocellirlar adetionta, and hepatocellirlar carcinoma are believed to represent a spectrum of changes that comprise the riatiiral history of iieoplasia. Each of these terms reflects our knowledge regarding the autonomy of the lesion and its biological potential the time of sampling. Foci of cellular alteration are believed to be reversible changes that may progress to neoplasia under the influence of certain environmental conditions o r external stimuli. Adenomas are believed to be nonreversible changes that may also progress to overt carcinomas with potential t o metastasize.
The term neoplastic tiodiile has served us well by bringing about a standardization of hepatoproliferative lesions at a time when historically there were numerous names for similar lesions in the rat. Consequently, the decision to modify that nomenclature is not made lightly. By changing nomenclature at this time, we risk introducing confusion in the minds of those pathologists who have accepted the term neoplastic tiodiile and are comfortable using it. However, because the revised nomenclature is consistent with traditional pathologic diagnoses for proliferative lesions in other epithelial tissues, it is anticipated that experienced toxicologic pathologists will readily utilize the revised nomenclature in evaluating conventional toxicity and carcinogenicity studies in rats.
